Wie hoch ist der Preis für Elbit Medical Technologies Ltd (EMTC-M)

Preis für Elbit Medical Technologies Ltd (EMTC-M) ist $0.07188945

Wie hoch ist die Marktkapitalisierung für Elbit Medical Technologies Ltd (EMTC-M)

Marktkapitalisierung für Elbit Medical Technologies Ltd (EMTC-M) ist $65.22K

Elbit Medical Technologies Ltd (EMTC-M) Aktiensplits

Elbit Medical Technologies Ltd functions as an investment holding company, with its core activities centered on the innovation, production, and global commercialization of therapeutic medical devices. The company maintains a presence across the United States, Europe, and other international territories. A key initiative involves the advancement of a magnetic resonance imaging (MRI) guided focused ultrasound treatment system, designed to tackle a range of medical challenges, including various cancers (oncology), gynecological conditions, neurological disorders, and tumors. Additionally, Elbit Medical Technologies is engaged in the extensive study and creation of medical products leveraging stem cells, predominantly sourced from umbilical cord blood. These stem cell applications are critical for bone marrow transplants in individuals affected by leukemia, lymphatic system cancers, non-malignant hematological diseases, and inherited metabolic genetic conditions. Headquartered in Petah Tikva, Israel, Elbit Medical Technologies Ltd is a wholly-owned subsidiary of Exigent Management Ltd.

Jahr	Aktien-Split	Multiplikator	Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.

Jahr

Aktien-Split

Multiplikator

Kumulierter Multiplikator

Nicht genügend Daten für die angegebenen Daten.

Unternehmen	Anzahl der Aktiensplits	Kumulierter Multiplikator	Land
Abbott Laboratories ABT.US	9	x285	US
Stryker Corporation SYK.US	9	x162	US
Medtronic plc MDT.US	7	x127	IE
Boston Scientific Corporation BSX.US	2	x4	US
Edwards Lifesciences Corporation EW.US	3	x12	US

Unternehmen

Anzahl der Aktiensplits

Kumulierter Multiplikator

Land